Anesthetic considerations in medium-chain acyl-CoA dehydrogenase deficiency
Journal of Cellular & Molecular Anesthesia,
Vol. 2 No. 2 (2017),
12 May 2017
AbstractIn the 1980’s, medium-chain acyl-CoA dehydrogenase deficiency (MCADD) was first described in the literature as three children who presented with coma, hypoglycemia, hyperammonemia, and fatty liver while fasting. These symptoms while similar to Reye’s Syndrome, were found to be due to an inability to metabolize medium chain fatty acids during fasting periods. Fatty acids are utilized by the body asessential fuel for skeletal and cardiac muscle, and as an important source of energy during fasting periods. Medium-chain acyl-CoA dehydrogenase is a mitochondrial enzyme required for the beta oxidation of medium chain fatty acids (C4-14), which is deficient in this syndrome. Anesthesiologists may come across these patients in their practice, as MCADD is the most common inhertited disorder of mitochondrial fatty acid oxidation. In addition to determining NPO timing and IV fluid selection, other preoperative issues anesthesiologists must consider are medication management to avoid metabolic decompensation. This manuscript will consider a pediatric patient with MCADD who presented to our pediatric hospital and received a general anesthetic following the guidelines created by ourmultidisciplinary perioperative team.
- medium-chain acyl-CoA dehydrogenase deficiency
- metabolic disorder
How to Cite
Stanley CA, Hale DE, Coates PM, et al. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res. 1983;17(11):877-884..
Wang SY, Kannan S, Shay D, Segal S, Datta S, Tsen L. Anesthetic considerations for a patient with compound heterozygous medium-chain Acyl-CoA dehydrogenase deficiency. Anesth Analg. 2002;94(6):1595-1597.
MD VCB, MPH JEOM. Anesthesia for Genetic, Metabolic, and Dysmorphic Syndromes of Childhood. Second edition. Philadelphia, PA: LWW; 2006.
Steiner LA, Studer W, Baumgartner ER, Frei FJ. Perioperative management of a child with very-long-chain acyl-coenzyme A dehydrogenase deficiency. Paediatr Anaesth. 2002;12(2):187-191.
Allen C, Perkins R, Schwahn B. A retrospective review of anesthesia and perioperative care in children with medium-chain acyl-CoA dehydrogenase deficiency. Paediatr Anaesth. November 2016.
Dearlove OR, Perkins R. MCAD deficiency and anaesthesia. Anaesthesia. 1995;50(3):265.
Justiz AC, Mayhew JF. Anesthesia in a child with medium-chain Acyl-CoA dehydrogenase deficiency. Paediatr Anaesth. 2006;16(12):1293-1294.
Matern D, Rinaldo P. Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. In: Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews(®). Seattle (WA): University of Washington, Seattle; 1993. http://www.ncbi.nlm.nih.gov/books/NBK1424/. Accessed December 8, 2016.
Gartner V, McGuire PJ, Lee PR. Child Neurology: medium-chain acyl-coenzyme A dehydrogenase deficiency. Neurology. 2015;85(4):e37-40.
Loughrey C, Bennett MJ. Screening for MCAD deficiency in newborns. BMJ. 2009;338:b971.
Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2005;6(3 Suppl):S3-5.
British Inherited Metabolic Diseases Group. Management of surgery in children with fat oxidation disorders. 2013. Available at: http://www.bimdg.org.uk/store/guidelines/ Management-of-surgery-in-children-with-fatoxidation- disordersv4-619512-22-05-.
Kleemann PP, Jantzen JP, Fenner R, Wiegand UW. [Preoperative increase in the plasma concentration of free fatty acids during minor elective interventions using a conventional anesthesia technic with enflurane]. Anaesthesist. 1986;35(10):604–608.
Fudickar A, Bein B. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol. 2009;75(5):339-344.
Farag E, Deboer G, Cohen BH, Niezgoda J. Metabolic acidosis due to propofol infusion. Anesthesiology. 2005;102(3):697-698-699.
American Society of Anesthesiology House of Delegates Committee on Standard and Practice. Standards for basic anesthetic monitoring. 2010.
American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology. 2011;114(3):495-511.
Sweet CB, Grayson S, Polak M. Management strategies for neonatal hypoglycemia. J Pediatr Pharmacol Ther JPPT Off J PPAG. 2013;18(3):199-208.
Harker HE, Emhardt JD, Hainline BE. Propionic acidemia in a four-month-old male: a case study and anesthetic implications. Anesth Analg. 2000;91(2):309-311.
Karagoz AH, Uzümcügil F, Celebi N, Canbay O, Ozgen S. Anesthetic management of a 2-year-old male with propionic acidemia. Paediatr Anaesth. 2006;16(12):1290-1291.
Schowalter DB, Matern D, Vockley J. In vitro correction of medium chain acyl CoA dehydrogenase deficiency with a recombinant adenoviral vector. Mol Genet Metab. 2005;85(2):88-95.
- Abstract Viewed: 2053 times
- PDF Downloaded: 2898 times